Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard F Jacobs

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Archives of Pediatrics & Adolescent Medicine|January 30, 2002
Ehrlichia chaffeensis seroprevalence among children in the southeast and south-central regions of the United StatesGary S Marshall, Richard F Jacobs, Gordon E Schutze, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2007
Single-dose pharmacokinetics of intravenous itraconazole and hydroxypropyl-beta-cyclodextrin in infants, children, and adolescentsSusan M Abdel-Rahman, Richard F Jacobs, Joseph Massarella, et al.
The Pediatric Infectious Disease Journal|June 24, 2010
Pharmacokinetics and tolerability of single-dose intravenous ertapenem in infants, children, and adolescentsSusan M Abdel-Rahman, Gregory L Kearns, Santiago Topelberg, et al.
Archives of Pediatrics & Adolescent Medicine|May 14, 2003
Antibodies reactive to Rickettsia rickettsii among children living in the southeast and south central regions of the United StatesGary S Marshall, Gordon G Stout, Richard F Jacobs, et al.
The Journal of Pediatrics|August 14, 2003
Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trialDavid W Kimberlin, Chin-Yu Lin, Pablo J Sánchez, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 22, 2009
Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous systemSara E Oliver, Gretchen A Cloud, Pablo J Sánchez, et al.
The Journal of Infectious Diseases|February 19, 2008
Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus diseaseDavid W Kimberlin, Edward P Acosta, Pablo J Sánchez, et al.
The Journal of Infectious Diseases|December 12, 2018
Blood Viral Load in Symptomatic Congenital Cytomegalovirus InfectionConcetta Marsico, Immaculada Aban, Huichien Kuo, et al.
Journal of the Pediatric Infectious Diseases Society|September 26, 2015
A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With Enterovirus SepsisMark J Abzug, Marian G Michaels, Ellen Wald, et al.
The Pediatric Infectious Disease Journal|December 2, 2009
Safety of oseltamivir compared with the adamantanes in children less than 12 months of ageDavid W Kimberlin, Marwan Shalabi, Mark J Abzug, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Archives of Pediatrics & Adolescent Medicine|January 30, 2002
Ehrlichia chaffeensis seroprevalence among children in the southeast and south-central regions of the United StatesGary S Marshall, Richard F Jacobs, Gordon E Schutze, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2007
Single-dose pharmacokinetics of intravenous itraconazole and hydroxypropyl-beta-cyclodextrin in infants, children, and adolescentsSusan M Abdel-Rahman, Richard F Jacobs, Joseph Massarella, et al.
The Pediatric Infectious Disease Journal|June 24, 2010
Pharmacokinetics and tolerability of single-dose intravenous ertapenem in infants, children, and adolescentsSusan M Abdel-Rahman, Gregory L Kearns, Santiago Topelberg, et al.
Archives of Pediatrics & Adolescent Medicine|May 14, 2003
Antibodies reactive to Rickettsia rickettsii among children living in the southeast and south central regions of the United StatesGary S Marshall, Gordon G Stout, Richard F Jacobs, et al.
The Journal of Pediatrics|August 14, 2003
Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trialDavid W Kimberlin, Chin-Yu Lin, Pablo J Sánchez, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 22, 2009
Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous systemSara E Oliver, Gretchen A Cloud, Pablo J Sánchez, et al.
The Journal of Infectious Diseases|February 19, 2008
Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus diseaseDavid W Kimberlin, Edward P Acosta, Pablo J Sánchez, et al.
The Journal of Infectious Diseases|December 12, 2018
Blood Viral Load in Symptomatic Congenital Cytomegalovirus InfectionConcetta Marsico, Immaculada Aban, Huichien Kuo, et al.
Journal of the Pediatric Infectious Diseases Society|September 26, 2015
A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With Enterovirus SepsisMark J Abzug, Marian G Michaels, Ellen Wald, et al.
The Pediatric Infectious Disease Journal|December 2, 2009
Safety of oseltamivir compared with the adamantanes in children less than 12 months of ageDavid W Kimberlin, Marwan Shalabi, Mark J Abzug, et al.
Pageof 5